Read More Pharma Industry News Sanofi strikes $805m deal with Principia Biopharma for multiple sclerosis drug development Sanofi and Principia Biopharma have announced a significant partnership to develop and commercialize PRN2246, a promising oral drug… bySrinathNovember 12, 2017
